MedPath

HEXACATH FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII

Phase 4
Conditions
Silent Myocardial Infarction
Stable Angina
Acute Coronary Syndrome
Interventions
Device: Titan 2 stents
Device: Cobalt-Chromium Bare Metal Stents
First Posted Date
2013-08-07
Last Posted Date
2014-01-08
Lead Sponsor
Hexacath, France
Target Recruit Count
1350
Registration Number
NCT01918150
Locations
🇫🇷

HIA Val de Grâce, Paris, France

🇫🇷

CH Henri Duffaut, Avignon, France

🇫🇷

Polyclinique de Bois Bernard, Bois-Bernard, France

and more 39 locations
© Copyright 2025. All Rights Reserved by MedPath